PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Early administration of tumor necrosis factor-alpha antagonist promotes survival of transplanted neural stem cells and axon myelination after spinal cord injury in rats.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 24887643 ↗2014Reported benefit

Early administration of tumor necrosis factor-alpha antagonist promotes survival of transplanted neural stem cells and axon myelination after spinal cord injury in rats.

RatSpinal cord injuryContusionSprague-DawleyFemaleEarly administration during the acute phase after injury

Model: Spinal cord contusion injury

Early etanercept suppressed TNF-alpha and apoptosis of transplanted neural stem cells, and combination therapy improved locomotor recovery, ventral horn neuron survival, cavity size, neurofilament-positive fibres and axon myelination.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.